Skip to main content

Table 2 Characteristics of patients with follow-up, who underwent 68Ga-DOTATOC-PET/MRI before PRRT and were used to assess the predictive value of 68Ga-DOTATOC-PET/MRI

From: Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient

All patients (N = 28)
Age (years)
 Median (range)66.1 (22–88)
SexN
 Male17
 Female11
PrimaryN
 Pancreas10
 Small intestine9
 CUP4
 Lungs1
 Rectum1
 Stomach1
 Kidney1
 Paraganglioma1
GradingN
 19
 214
 33
 Unknown 
Treatment response
 Treatment response23
 No response5
Nuclide
177Lutetium15
90Yttrium13
NETTER-1 protocol 
 yes3
 no25
Cycles before follow-up
 124
 21
 43
Therapeutic Activity
 Mean (range)7.92 (4–30.2)